Expression of the B cell inhibitory molecule CD22 in patients with systemic lupus erythematosus.

被引：0
|
作者：
Liossis, SNC
Dimopoulos, MA
Sfikakis, PP
机构：
[1] Laikon Hosp, Dept Proped Med, Athens, Greece
[2] Alexandra Hosp, Dept Therapeut, Athens, Greece
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
33
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [41] Herpes zoster infection in patients with systemic lupus erythematosus.
    Kang, TY
    Kim, TH
    Jun, JB
    Jung, SS
    Bae, SC
    Kim, SY
    Yoo, DH
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S245 - S245
  • [42] Muscular involvement in 600 patients with systemic lupus erythematosus.
    Font, J
    Ramos-Casals, M
    Gil, V
    Claver, G
    de-la-Red, G
    Jimenez, S
    Garcia-Carrasco, M
    Cervera, R
    Ingelmo, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S442 - S442
  • [43] Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L) Controls Activation of Human CD27+IgM+ B Cells
    Dijke, E.
    Derkatz, K.
    Pearcey, J.
    Wong, F.
    Motyka, B.
    West, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S47 - S47
  • [44] Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus.
    Furie, Richard A.
    Scheinberg, Morton A.
    Leon, Gustavo
    Ramiterre, Edgar B.
    Thomas, Matthew
    Martin, Renee S.
    Petri, Michelle A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4169 - 4169
  • [45] Angiogenic and Antiangiogenic Factors in Patients with Systemic Lupus Erythematosus.
    de Jesus, Guilherme Ramires
    Oliveira, Camila Souto
    dos Santos, Flavia Cunha
    de Jesus, Nilson Ramires
    Porto, Luis Cristovao
    Levy, Roger A.
    Klumb, Evandro Mendes
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1157 - S1157
  • [46] Survival and cause of death in patients with systemic lupus erythematosus.
    Gonzàlez-Montagut, C
    López-Longo, FJ
    Montoro, M
    Vázquez-Coleman, J
    Nuño, L
    Ortega, C
    González, CM
    Monteagudo, I
    Carreño, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S186 - S186
  • [47] Predictors of fetal loss in patients with systemic lupus erythematosus.
    Gregg, L
    Sibbitt, WL
    Patel, S
    Maldonado, ME
    Bankhurst, AD
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S289 - S289
  • [48] Vλ repertoire abnormalities in patients with systemic lupus erythematosus.
    Lee, J
    Lipsky, PE
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S235 - S235
  • [49] CD5 Expression in B Cells from Patients with Systemic Lupus Erythematosus
    Youinou, Pierre
    Renaudineau, Yves
    CRITICAL REVIEWS IN IMMUNOLOGY, 2011, 31 (01) : 31 - 42
  • [50] CD4 CXCR3 expression is decreased in active systemic lupus erythematosus.
    Amoura, Z
    Combadiere, C
    Faure, S
    Debre, P
    Gorochov, G
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S284 - S284
12345